Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4574235
Max Phase: Preclinical
Molecular Formula: C19H15ClN2O2S
Molecular Weight: 370.86
Molecule Type: Unknown
Associated Items:
ID: ALA4574235
Max Phase: Preclinical
Molecular Formula: C19H15ClN2O2S
Molecular Weight: 370.86
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=S(=O)(NN=C(c1ccccc1)c1ccccc1)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C19H15ClN2O2S/c20-17-11-13-18(14-12-17)25(23,24)22-21-19(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1-14,22H
Standard InChI Key: GRFBRNXLASCHAU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 370.86 | Molecular Weight (Monoisotopic): 370.0543 | AlogP: 4.07 | #Rotatable Bonds: 5 |
Polar Surface Area: 58.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.04 | CX Basic pKa: | CX LogP: 5.07 | CX LogD: 5.07 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.54 | Np Likeness Score: -1.10 |
1. Arshia, Begum F, Almandil NB, Lodhi MA, Khan KM, Hameed A, Perveen S.. (2019) Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico., 27 (6): [PMID:30738655] [10.1016/j.bmc.2019.01.043] |
Source(1):